Skip to content
National Opioids Settlement

Purdue/Sacklers Settlements

Purdue/Sacklers Settlement

  • Government Entity Direct Shareholders Settlement Agreement – June 17, 2025
    • Exhibit B
    • Exhibit C
    • Exhibit E
    • Exhibit G
    • Exhibit I
    • Exhibit K
    • Exhibit M1-M5
    • Exhibit O
    • Exhibit R
    • Exhibit S
    • Exhibit V
    • Exhibit W
  • Master Shareholder Settlement Agreement – November 7, 2025
    • Exhibit A
    • Exhibit B
    • Exhibit C
    • Exhibit E
    • Exhibit H
    • Exhibit I
    • Exhibit J
    • Exhibit K
    • Exhibit L
    • Exhibit M1-M2
    • Exhibit N
    • Exhibit O
    • Exhibit R
    • Exhibit T
    • Exhibit V
    • Exhibit W
    • Exhibit X
    • Exhibit Z
    • Exhibit AA
    • Annex A
    • Annex C
    • Annex E
    • Annex F
    • Annex G
  • Purdue Eighteenth Amended Plan of Reorganization (November 14, 2025)
  • Notice of Bankruptcy Court Order Confirming Bankruptcy Plan and Enjoining Continuation of Proceedings as to Debtor Purdue Pharma, L.P., Affiliated Debtors, and Related Parties (November 21, 2025)
  • Findings of Fact, Conclusions of Law, and Order Confirming the Eighteenth Amended Joint Chapter 11 Plan of Reorganization of Purdue Pharma L.P. and Its Affiliated Debtors (November 21, 2025)
  • Purdue Pharma Findings of Fact, Conclusions of Law, and Confirmation Order (November 18, 2025)
  • Purdue Pharma Settlement Estimated Distribution Chart
  • Docusign Instructions for Eligible Settling Entities
  • HOME
  • NEWS
  • RISKS & ASSUMPTIONS
  • MDL ORDERS
  • TRIBAL SETTLEMENTS
  • FEE PANEL DOCUMENTS

All rights reserved